Disease Activity Assessment in IBD
Open Access
- 1 April 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 21 (4), 824-831
- https://doi.org/10.1097/mib.0000000000000341
Abstract
In the current management paradigm, mucosal healing is preferred over clinical remission as a therapeutic end point in inflammatory bowel disease (IBD) because of the benefits engendered with respect to durability of remission. Colonoscopy, however, is not suitable for regular disease monitoring, and routine clinical assessment is often inaccurate with respect to endoscopic disease activity. The current investigation set out to characterize the relationship that exists between endoscopically determined IBD activity and clinical and biochemical measures of disease severity and to determine clinically useful thresholds for use in clinical practice. Patients attending for colonoscopy with known or suspected IBD were recruited. Clinical disease activity was recorded as per the Harvey–Bradshaw Index for Crohn's disease or the simple clinical colitis activity index for ulcerative colitis. Endoscopic activity was recorded using the simple endoscopic score for Crohn's disease or the modified Baron score for ulcerative colitis. Receiver operating characteristic analysis determined the predictive value and optimal predictive thresholds for clinical and biomarker data. The Harvey–Bradshaw Index was not able to distinguish active from inactive Crohn's disease. The sensitivity, specificity, and positive and negative predictive values of simple clinical colitis activity index to detect endoscopic active disease were 43%, 96%, 94%, and 51%, respectively. Any elevation of C-reactive protein or fecal calprotectin was predictive of active mucosal disease, however, no lower threshold could be identified that predicted disease in remission. C-reactive protein and fecal calprotectin are useful for the identification of endoscopically active IBD, but normal results do not confirm endoscopic remission.Keywords
This publication has 33 references indexed in Scilit:
- Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970–2004)The American Journal of Gastroenterology, 2012
- Tu1303 Risk of Surgery Following Diagnosis in Adult and Pediatric Ulcerative Colitis Patients: A Systematic Review and Meta-AnalysisGastroenterology, 2012
- Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's diseaseScandinavian Journal of Gastroenterology, 2012
- Development of the Crohnʼs disease digestive damage score, the Lémann scoreInflammatory Bowel Diseases, 2011
- Dosage adjustment during long-term adalimumab treatment for Crohnʼs disease: Clinical efficacy and pharmacoeconomicsInflammatory Bowel Diseases, 2011
- Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's DiseaseGastroenterology, 2010
- Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAIThe American Journal of Gastroenterology, 2010
- Factors predicting the outcome of disease activity assessment in Crohnʼs diseaseInflammatory Bowel Diseases, 2009
- W1165 Clinical Assessment of Ulcerative Colitis Activity Correlates Poorly with Endoscopic Disease Activity.Gastroenterology, 2009
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980